title: Comparison of Skin Toxic Effects Associated With Gefitinib, Erlotinib, or Afatinib Treatment for Non-Small Cell Lung Cancer.
authors.affiliation: Department of Dermatology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei.
authors.forename: Kai-Lung
authors.initials: KL
authors.lastname: Chen
authors.affiliation: Department of Oncology, National Taiwan University Hospital, Taipei3Department of Urology, National Taiwan University College of Medicine, Taipei.
authors.forename: Chia-Chi
authors.initials: CC
authors.lastname: Lin
authors.affiliation: Department of Dermatology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei.
authors.forename: Yung-Tsu
authors.initials: YT
authors.lastname: Cho
authors.affiliation: Department of Dermatology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei.
authors.forename: Che-Wen
authors.initials: CW
authors.lastname: Yang
authors.affiliation: Department of Dermatology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei.
authors.forename: Yi-Shuan
authors.initials: YS
authors.lastname: Sheen
authors.affiliation: Department of Surgery, National Taiwan University Hospital Hsin-Chu Branch, Hsin-Chu City.
authors.forename: Hsiao-En
authors.initials: HE
authors.lastname: Tsai
authors.affiliation: Department of Dermatology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei.
authors.forename: Chia-Yu
authors.initials: CY
authors.lastname: Chu
mesh_terms: D017486:Acneiform Eruptions / Q000139:chemically induced / Q000453:epidemiology; D000077716:Afatinib; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D015331:Cohort Studies; D057176:Compassionate Use Trials; D003430:Cross-Sectional Studies; D003875:Drug Eruptions / Q000175:diagnosis* / Q000209:etiology*; D000069347:Erlotinib Hydrochloride / Q000009:adverse effects* / Q000627:therapeutic use; D000077156:Gefitinib; D006801:Humans; D007057:Ichthyosis / Q000139:chemically induced / Q000453:epidemiology; D008175:Lung Neoplasms / Q000188:drug therapy*; D010304:Paronychia / Q000139:chemically induced / Q000453:epidemiology; D011537:Pruritus / Q000139:chemically induced / Q000453:epidemiology; D011799:Quinazolines / Q000009:adverse effects* / Q000627:therapeutic use; D012189:Retrospective Studies
chemical_list: D011799:Quinazolines; D000077716:Afatinib; D000069347:Erlotinib Hydrochloride; D000077156:Gefitinib